Literature DB >> 4083859

Effect of a lactobacillus preparation on the absorption of oral ampicillin.

R L Yost, V P Gotz.   

Abstract

Lactobacillus preparations have been demonstrated to be beneficial in the prevention of antibiotic-associated diarrhea resulting from ampicillin. Since the bioavailability of oral ampicillin is known to be affected by food and fluid volume, a study to evaluate the influence of a lactobacillus product on ampicillin bioavailability was performed. Twelve healthy volunteers, male and female, were studied in a randomized three-way cross-over study. Each received ampicillin alone, ampicillin with a lactobacillus preparation, and ampicillin followed 1 h later by the lactobacillus preparation. Blood was sampled over a 6-h time period. Ampicillin content was determined by high-pressure liquid chromatography. Area under the concentration-time curve, area under the first moment of the concentration-time curve, maximum concentration of drug in plasma, time to maximum concentration of drug in plasma, and mean residence time were determined for each study interval. No differences in maximum concentration of drug in plasma, time to maximum concentration of drug in plasma, area under the concentration-time curve, or mean residence time were seen for either males or females or the combined group. The lactobacillus preparation as used in this study did not appear to interfere with the bioavailability of oral ampicillin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4083859      PMCID: PMC180317          DOI: 10.1128/AAC.28.6.727

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Antimicrobial agent-induced diarrhea--a bacterial disease.

Authors:  W L George; V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

2.  Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects.

Authors:  P G Welling; H Huang; P A Koch; W A Craig; P O Madsen
Journal:  J Pharm Sci       Date:  1977-04       Impact factor: 3.534

3.  Oral bacteriotherapy in clinical practice. I. The use of different preparations in infants treated with antibiotics.

Authors:  G Zoppi; A Deganello; G Benoni; F Saccomani
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

4.  Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation.

Authors:  V Gotz; J A Romankiewicz; J Moss; H W Murray
Journal:  Am J Hosp Pharm       Date:  1979-06

5.  Rapid determination of amoxycillin (clamoxyl) and ampicillin (penbritin) in body fluids of many by means of high-performance liquid chromatography.

Authors:  T B Vree; Y A Hekster; A M Baars; E Van der Kleijn
Journal:  J Chromatogr       Date:  1978-05-01

Review 6.  Diarrhea and colitis associated with antimicrobial therapy in man and animals.

Authors:  W L George; R D Rolfe; V L Sutter; S M Finegold
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

Review 7.  Medical management of antimicrobial-associated diarrhea and colitis.

Authors:  V P Gotz; K H Rand
Journal:  Pharmacotherapy       Date:  1982 Mar-Apr       Impact factor: 4.705

8.  Exogenous lactobacilli fed to man - their fate and ability to prevent diarrheal disease.

Authors:  M L Clements; M M Levine; P A Ristaino; V E Daya; T P Hughes
Journal:  Prog Food Nutr Sci       Date:  1983

9.  Bacterial interference between Clostridium difficile and normal fecal flora.

Authors:  R D Rolfe; S Helebian; S M Finegold
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

10.  Spectrum of antibiotic-associated diarrhoea.

Authors:  A H Lishman; I J Al-Jumaili; C O Record
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

View more
  1 in total

1.  Impact of Lactobacillus acidophilus on the normal intestinal microflora after administration of two antimicrobial agents.

Authors:  A Lidbeck; C Edlund; J A Gustafsson; L Kager; C E Nord
Journal:  Infection       Date:  1988       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.